Literature DB >> 11817701

Radiation-induced glioma presenting as diffuse leptomeningeal gliomatosis: a case report.

M D Hill1, I Mackenzie, W P Mason.   

Abstract

BACKGROUND: Leptomeningeal gliomatosis is a rare and fatal disease.
METHODS: Case report.
RESULTS: We report the case of a man who was presented with severe intractable headaches, lymphocytic CSF pleocytosis, and spinal leptomeningeal enhancement on contrast MRI. Meningeal biopsy demonstrated diffuse infiltration by malignant glial cells, and symptom alleviation was achieved by CSF diversion. He later developed an enhancing thalamic tumor arising within the treatment field of a remotely irradiated pituitary adenoma. Subsequent management included chemotherapy and further radiotherapy with transient response, before death from leptomeningeal and parenchymal tumor progression 16 months after diagnosis.
CONCLUSION: We report a unique case embodying two rare conditions: radiation induced glioma and leptomeningeal gliomatosis. Our patient's course is novel in that symptomatic relief was achieved with CSF diversion and a combination of chemotherapy and focal radiation allowed prolonged survival.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11817701     DOI: 10.1023/a:1013337802429

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  20 in total

1.  Heterotopic glial nests in the subarachnoid space; histopathologic characteristics, mode of origin and relation to meningeal gliomas.

Authors:  I S COOPER; J W KERNOHAN
Journal:  J Neuropathol Exp Neurol       Date:  1951-01       Impact factor: 3.685

2.  Meningeal gliomatosis presenting as multiple cerebral infarcts: a case report.

Authors:  M Moonis; T W Smith
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

3.  Homozygous p53 gene mutation in a radiation-induced glioblastoma 10 years after treatment for an intracranial germ cell tumor: case report.

Authors:  M Tada; Y Sawamura; H Abe; R Iggo
Journal:  Neurosurgery       Date:  1997-02       Impact factor: 4.654

4.  Primary diffuse leptomeningeal gliomatosis.

Authors:  P Bailey; Y Robitaille
Journal:  Can J Neurol Sci       Date:  1985-08       Impact factor: 2.104

Review 5.  A report on radiation-induced gliomas.

Authors:  M Salvati; M Artico; R Caruso; G Rocchi; E R Orlando; F Nucci
Journal:  Cancer       Date:  1991-01-15       Impact factor: 6.860

6.  Leptomeningeal metastasis from supratentorial malignant gliomas.

Authors:  I Awad; J W Bay; L Rogers
Journal:  Neurosurgery       Date:  1986-08       Impact factor: 4.654

7.  Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk.

Authors:  R W Tsang; N J Laperriere; W J Simpson; J Brierley; T Panzarella; H S Smyth
Journal:  Cancer       Date:  1993-10-01       Impact factor: 6.860

8.  Radiation-associated gliomas: a report of four cases and analysis of postradiation tumors of the central nervous system.

Authors:  B H Liwnicz; T S Berger; R G Liwnicz; B S Aron
Journal:  Neurosurgery       Date:  1985-09       Impact factor: 4.654

9.  Meningeal gliomatosis with "negative" CSF cytology: the value of GFAP staining.

Authors:  L R Wechsler; R A Gross; D C Miller
Journal:  Neurology       Date:  1984-12       Impact factor: 9.910

10.  Intrathecal chemotherapy with ACNU for meningeal gliomatosis.

Authors:  T K Yoshida; E Beuls; K Shimizu; A Koulousakis; V Sturm
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

View more
  2 in total

Review 1.  Radiation-induced gliomas: a comprehensive review and meta-analysis.

Authors:  Ryuya Yamanaka; Azusa Hayano; Tomohiko Kanayama
Journal:  Neurosurg Rev       Date:  2016-10-05       Impact factor: 3.042

Review 2.  Secondary Intracranial Tumors Following Radiotherapy for Pituitary Adenomas: A Systematic Review.

Authors:  Ryuya Yamanaka; Eisuke Abe; Toshiteru Sato; Azusa Hayano; Yasuo Takashima
Journal:  Cancers (Basel)       Date:  2017-08-08       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.